Market Place
Sourcing Support
All News #Library
Others
MSN Launches Sacubitril & Valsartan Tablet in USA After Legal Win
19 Aug 2025 //
PR NEWSWIRE
U.S. Appeals Court Affirms Delaware Rulings for Acadia in Nuplazi
09 Jun 2025 //
BUSINESSWIRE
Exelixis Updates On Second Patent Litigation Trial With MSN Labs
15 Oct 2024 //
BUSINESSWIRE
Polpharma & MSN Lab Announce Strategic Distribution Partnership
23 Sep 2024 //
PRESS RELEASE
Exelixis Announces Update on Patent Litigation with MSN Laboratories
19 Jan 2023 //
BUSINESSWIRE
Breckenridge Launches Lacosamide Tablets Manufactured by MSN Laboratories
19 Apr 2022 //
PRNEWSWIRE
BI gets injunction against Dr. Reddy’s Labs, MSN Labs for anti-diabetes drug
26 Oct 2021 //
ECONOMICTIMES
MSN Labs launches Empagliflozin tablets for diabetes management in India
18 Oct 2021 //
EXPRESSPHARMA
Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19
09 Oct 2021 //
REUTERS
Aurobindo Pharma, MSN Labs seek DGCI nod for Merck`s molnupiravir
08 Oct 2021 //
ECONOMIC TIMES
MSN labs launch indigenous drug Posaconazole to treat black fungus
21 May 2021 //
INDIATODAY
Lilly signs two pacts with MSN Labs and Torrent Pharma, for Covid drug
14 May 2021 //
THEHINDUBUSINESSLINE
Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole
22 Apr 2021 //
PRNEWSWIRE
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation
25 Mar 2021 //
BIOSPACE
RedHill Biopharma Announces Settlement of Movantik®
25 Mar 2021 //
PRNEWSWIRE
MSN Labs introduces oral antiviral generic drug, 400mg Favilow to treat COVID-19
17 Sep 2020 //
PHARMABIZ
Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow
15 Sep 2020 //
EXPRESS PHARMA
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
23 Jul 2019 //
FIERCE PHARMA
FDA Approves First Lyrica Generics From 9 Sponsors
22 Jul 2019 //
RAPS
Cadila receives Indian process patent for Sitagliptin (Januvia)
01 Mar 2016 //
TWOFOUR INSIGHT
Telangana regulator inspects 12 units of major pharma firms for quality issues
19 Feb 2016 //
FINANCIAL EXPRESS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.